The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with post-traumatic stress disorder (PTSD) ...

Workplace trauma affects a wide range of employees—employers who prioritize flexible policies, non-judgmental communication, and mental health resources create safer, more resilient teams.

Otsuka Pharma (OTCPK:OTSKY) and H. Lundbeck (OTCPK:HLBBF) draws efficacy concerns for their PTSD therapy from the FDA ahead ...

His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs.

Once again, he informed his command that he needed to deploy to Iraq, and after another lengthy back-and-forth, they relented ...

The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug in combination with Viatris' Zoloft for the treatment of adults with PTSD.

The psychological and emotional harm of restraining a child during a medical procedure is causing more trauma than necessary.